Pandora A/S
Trading in Pandora A/S Shares by Board Members, Executives and Associated Persons
Trading in Pandora A/S Shares by Board Members, Executives and Associated Persons
Pandora A/S has been notified of transactions in the Pandora A/S share by a person discharging managerial responsibilities and/or closely associated persons.
Lilian Fossum Biner, Board member of Pandora A/S, has reported the purchase of 300 shares at a total price of DKK 408,113.49 and now holds a total of 665 shares in the company.
ABOUT PANDORA
Pandora is the world's largest jewellery brand, specialising in the design, crafting and marketing of accessible luxury jewellery made from high-quality materials. Each piece is created to inspire self-expression, allowing people to share their stories and passions through meaningful jewellery. Pandora jewellery is sold in more than 100 countries through 6,800 points of sale, including more than 2,700 concept stores.
Headquartered in Copenhagen, Denmark, Pandora employs 37,000 people worldwide and crafts its jewellery using only recycled silver and gold. Pandora is committed to leadership in sustainability and has set out to halve greenhouse gas emissions across its value chain by 2030. Pandora is listed on the Nasdaq Copenhagen stock exchange and generated revenue of DKK 31.7 billion (EUR 4.2 billion) in 2024.
CONTACT
For more information, please contact:
Investor Relations BILAL AZIZ VP, Investor Relations & Treasury +45 3137 9486 biazi@pandora.net | Corporate Communications JOHAN MELCHIOR VP, Media Relations & Public Affairs +45 4060 1415 jome@pandora.net |
ADAM FUGLSANG Director, Investor Relations +45 6167 7425 adfug@pandora.net |
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Basilea Pharmaceutica AG, Allschwil8.7.2025 07:15:00 CEST | Press release
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Novartis Pharma AG8.7.2025 07:15:00 CEST | Press release
Novartis receives approval for first malaria medicine for newborn babies and young infants
dsm-firmenich8.7.2025 07:00:00 CEST | Press release
Weekly progress on share repurchase program to cover share plans and reduce capital
Corbion8.7.2025 07:00:00 CEST | Press release
Corbion announces Executive Committee changes to strengthen its leadership structure
Fluence8.7.2025 04:00:00 CEST | Press release
Fluence Chosen for 300 MW / 600 MWh Wellington Battery Energy Storage System for AMPYR Australia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom